صفحة النتائج 2 القطاع: الرعاية الصحية الصناعة: شركات تصنيع الأدوية - عامة سوق الأسهم - العروض والأسعار
قائمة بجميع الأوراق المالية والأسهم مع الأسعار، والقيم السوقية، ونسبة السعر إلى الربح، والأرباح للسهم الواحد
جميع البلدان
- {{country.name}}
- جميع البلدان
- الولايات المتحدة (50)
- الأرجنتين (13)
- أستراليا (1)
- النمسا (13)
- البرازيل (14)
- كندا (2)
- تشيلي (4)
- الصين (22)
- فنلندا (2)
- فرنسا (3)
- ألمانيا (58)
- هونغ كونغ (4)
- هنغاريا (1)
- الهند (20)
- إندونيسيا (1)
- إيطاليا (5)
- اليابان (9)
- المكسيك (14)
- سنغافورة (1)
- كوريا الجنوبية (3)
- إسبانيا (1)
- السويد (3)
- سويسرا (6)
- تايوان (1)
- تركيا (1)
- المملكة المتحدة (20)
جميع منصات التبادل
- {{item.name}}
- جميع منصات التبادل
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
الرعاية الصحية (279)
- {{item.name}}
- جميع القطاعات
- الرعاية الصحية (279)
شركات تصنيع الأدوية - عامة (279)
- {{item.name}}
- جميع الصناعات
- التكنولوجيا الحيوية (2611)
- شركات تصنيع الأدوية - عامة (279)
- شركات تصنيع الأدوية - متخصصة وعامة (1705)
- خطط الرعاية الصحية (57)
- منشآت الرعاية الطبية (553)
- متاجر التجزئة الصيدلانية (155)
- خدمات المعلومات الصحية (419)
- الأجهزة الطبية (913)
- الأدوات والمستلزمات الطبية (501)
- التشخيص والبحث (427)
- التوزيع الطبي (138)
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS |
|---|
| الاسم الاسم | السعر السعر |
مخطط 24 ساعة% 7 أيام 24 ساعة% و7 أيام |
القيمة السوقية القيمة السوقية | الحجم حجم التداول | القاع (24 ساعة) | القمة (24 ساعة) | القيمة السوقية | نسبة السعر/الأرباح | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJB34.SA | $57.5 11.65 USD |
-0.57
|
$2.08T 420.62B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.08T 420.62B USD | 17.01 | $3.38 0.69 USD | |
| Johnson & Johnson JNJ.MX | $2,946.5 174.47 USD |
-0.46
|
$7.09T 419.78B USD | $363 21.49 USD | $2,946.5 174.47 USD | $2,950 174.68 USD | $7.09T 419.78B USD | 16.98 | $173.46 10.27 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $65.45 13.27 USD |
-0.83
|
$1.85T 374.92B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.85T 374.92B USD | 78.85 | $0.83 0.17 USD | |
| AbbVie Inc. ABBV.MX | $3,584 212.22 USD |
+0.68
|
$6.33T 374.86B USD | $70 4.14 USD | $3,572.99 211.56 USD | $3,584 212.22 USD | $6.33T 374.86B USD | 79.27 | $45.21 2.68 USD | |
| Johnson & Johnson JNJ.F | $135.22 147.81 USD |
+0.1
|
$325.35B 355.65B USD | $232 253.61 USD | $133.88 146.35 USD | $136.48 149.19 USD | $325.35B 355.65B USD | 17.05 | $7.93 8.67 USD | |
| Johnson & Johnson JNJ.VI | $134.46 146.98 USD |
-0.37
|
$323.52B 353.65B USD | $134 146.48 USD | $133.66 146.11 USD | $135.34 147.94 USD | $323.52B 353.65B USD | 17.02 | $7.9 8.64 USD | |
| AbbVie Inc. 4AB.F | $163.4 178.62 USD |
0
|
$288.63B 315.51B USD | $27 29.51 USD | $163.4 178.62 USD | $164 179.27 USD | $288.63B 315.51B USD | 79.32 | $2.06 2.25 USD | |
| AbbVie Inc. ABBV.VI | $163.2 178.4 USD |
-0.24
|
$288.28B 315.13B USD | $54 59.03 USD | $161.4 176.43 USD | $163.6 178.84 USD | $288.28B 315.13B USD | 79.22 | $2.06 2.25 USD | |
| AbbVie Inc. 4AB.DE | $163.2 178.4 USD |
-0.12
|
$288.28B 315.13B USD | $1.07K 1.17K USD | $161.2 176.21 USD | $164.6 179.93 USD | $288.28B 315.13B USD | 79.22 | $2.06 2.25 USD | |
| Novartis AG NVS.BA | $33,475 39.57 USD |
+2.06
|
$261.26T 308.82B USD | $519 0.61 USD | $33,175 39.21 USD | $33,475 39.57 USD | $261.26T 308.82B USD | 2.26 | $14.76K 17.44 USD | |
| AstraZeneca PLC AZN.BA | $42,200 49.88 USD |
+1.99
|
$256.62T 303.33B USD | $921 1.09 USD | $41,400 48.94 USD | $42,325 50.03 USD | $256.62T 303.33B USD | 7.34 | $5.75K 6.79 USD | |
| Roche Holding AG ROGN.MX | $5,791.5 342.93 USD |
0
|
$4.86T 288.06B USD | $30 1.78 USD | $5,791.5 342.93 USD | $5,791.5 342.93 USD | $4.86T 288.06B USD | 24.09 | $240.35 14.23 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Merck & Co., Inc. MRK.BA | $18,200 21.51 USD |
+1.53
|
$224.6T 265.48B USD | $11.76K 13.9 USD | $18,025 21.31 USD | $18,225 21.54 USD | $224.6T 265.48B USD | 0.22 | $79.57K 94.05 USD | |
| Novartis AG N1VS34.SA | $63.23 12.82 USD |
-1.6
|
$1.25T 253.12B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.25T 253.12B USD | 17.56 | $3.6 0.73 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.27T 252.73B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.27T 252.73B USD | 17.00 | $123.02 7.28 USD | |
| Roche Holding AG RHHBF | $336.17 — |
-0.84
|
$252.29B — | $3 — | $336.17 — | $336.17 — | $252.29B — | 26.95 | $12.47 — | |
| AstraZeneca PLC AZNN.MX | $1,366 80.88 USD |
+1.56
|
$4.26T 252.27B USD | $93 5.51 USD | $1,366 80.88 USD | $1,366 80.88 USD | $4.26T 252.27B USD | 28.52 | $47.88 2.84 USD | |
| AstraZeneca PLC A1ZN34.SA | $66.2 13.42 USD |
-3.62
|
$1.23T 249.6B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.23T 249.6B USD | 28.29 | $2.34 0.47 USD | |
| Roche Holding AG RHO6.F | $34.72 37.95 USD |
+0.46
|
$223.59B 244.41B USD | $8 8.75 USD | $34.72 37.95 USD | $34.72 37.95 USD | $223.59B 244.41B USD | 25.15 | $1.38 1.51 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| AstraZeneca PLC AZNCF | $143.1 — |
-0.61
|
$221.83B — | $2.16K — | $136.15 — | $143.1 — | $221.83B — | 28.96 | $4.94 — | |
| Merck & Co., Inc. MRCK34.SA | $53.71 10.89 USD |
-2.35
|
$1.08T 218.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.08T 218.68B USD | 11.07 | $4.85 0.98 USD | |
| Merck & Co., Inc. MRK.MX | $1,466 86.81 USD |
-1.15
|
$3.68T 217.97B USD | $152 9 USD | $1,466 86.81 USD | $1,475 87.34 USD | $3.68T 217.97B USD | 11.04 | $132.73 7.86 USD | |
| AstraZeneca PLC ZEG.F | $124.8 136.42 USD |
+0.85
|
$195.23B 213.41B USD | $78 85.26 USD | $124.8 136.42 USD | $125.05 136.7 USD | $195.23B 213.41B USD | 28.49 | $4.38 4.79 USD | |
| AstraZeneca PLC ZEGA.F | $62 67.77 USD |
+0.81
|
$195.16B 213.34B USD | $30 32.79 USD | $62 67.77 USD | $62 67.77 USD | $195.16B 213.34B USD | 28.31 | $2.19 2.39 USD | |
| Novartis AG NOTA.F | $98.6 107.78 USD |
-0.6
|
$194.74B 212.88B USD | $4 4.37 USD | $98 107.13 USD | $99.2 108.44 USD | $194.74B 212.88B USD | 17.54 | $5.62 6.14 USD | |
| Amgen Inc. AMGN.BA | $11,300 13.36 USD |
+3.2
|
$178.66T 211.18B USD | $1.3K 1.53 USD | $11,050 13.06 USD | $11,300 13.36 USD | $178.66T 211.18B USD | 0.17 | $63.44K 74.98 USD | |
| Merck & Co., Inc. MRK.SN | $78.71 — |
+2.67
|
$197.64B — | $0 — | $0 — | $0 — | $197.64B — | 11.44 | $6.88 — | |
| Gilead Sciences, Inc. GILD.BA | $33,200 39.24 USD |
+4.16
|
$162.49T 192.07B USD | $1.7K 2.01 USD | $32,675 38.62 USD | $33,225 39.27 USD | $162.49T 192.07B USD | 6.03 | $5.5K 6.51 USD | |
| Pfizer Inc. PFE.BA | $7,000 8.27 USD |
+2.64
|
$156.44T 184.91B USD | $9.41K 11.13 USD | $6,870 8.12 USD | $7,000 8.27 USD | $156.44T 184.91B USD | 2.19 | $3.19K 3.77 USD | |
| Merck & Co., Inc. MRK.VI | $67.3 73.57 USD |
-0.88
|
$168.99B 184.73B USD | $244 266.72 USD | $66.8 73.02 USD | $67.8 74.11 USD | $168.99B 184.73B USD | 11.14 | $6.04 6.6 USD | |
| Merck & Co., Inc. 6MK.DE | $67.1 73.35 USD |
-1.32
|
$168.49B 184.18B USD | $5.02K 5.49K USD | $66.7 72.91 USD | $67.9 74.22 USD | $168.49B 184.18B USD | 11.05 | $6.07 6.64 USD | |
| Merck & Co., Inc. 6MK.F | $67 73.24 USD |
-2.33
|
$168.24B 183.91B USD | $120 131.18 USD | $67 73.24 USD | $68 74.33 USD | $168.24B 183.91B USD | 11.03 | $6.07 6.64 USD | |
| Amgen Inc. AMGN34.SA | $56.75 11.5 USD |
-0.16
|
$854.42B 173.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $854.42B 173.18B USD | 25.67 | $2.21 0.45 USD | |
| Amgen Inc. AMGN.MX | $5,429.5 321.49 USD |
0
|
$2.92T 172.87B USD | $67 3.97 USD | $0 0 USD | $0 0 USD | $2.92T 172.87B USD | 25.64 | $211.75 12.54 USD | |
| Amgen Inc. 0R0T.IL | $282.25 — |
+0.89
|
$154.69B — | $38 — | $0 — | $0 — | $154.69B — | 19.01 | $14.84 — | |
| Gilead Sciences, Inc. GILD34.SA | $305.57 61.93 USD |
0
|
$760.84B 154.21B USD | $0 0 USD | $0 0 USD | $0 0 USD | $760.84B 154.21B USD | 22.78 | $13.41 2.72 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,080 123.16 USD |
0
|
$2.6T 154.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6T 154.02B USD | 22.67 | $91.73 5.43 USD | |
| Pfizer Inc. PFIZ34.SA | $33.1 6.71 USD |
+0.55
|
$752.74B 152.57B USD | $0 0 USD | $0 0 USD | $0 0 USD | $752.74B 152.57B USD | 16.97 | $1.95 0.4 USD | |
| Pfizer Inc. PFE.MX | $452.5 26.79 USD |
+0.42
|
$2.57T 152.33B USD | $429 25.4 USD | $450 26.65 USD | $452.5 26.79 USD | $2.57T 152.33B USD | 16.99 | $26.63 1.58 USD | |
| Amgen Inc. AMG.F | $248.6 271.75 USD |
+1.24
|
$133.7B 146.15B USD | $200 218.63 USD | $245.55 268.42 USD | $245.65 268.53 USD | $133.7B 146.15B USD | 25.70 | $9.67 10.57 USD | |
| Amgen Inc. AMGN.VI | $248.15 271.26 USD |
+0.14
|
$133.43B 145.86B USD | $0 0 USD | $245.4 268.26 USD | $248.15 271.26 USD | $133.43B 145.86B USD | 25.74 | $9.64 10.54 USD | |
| Amgen Inc. AMG.DE | $248.1 271.21 USD |
+0.06
|
$133.4B 145.83B USD | $61 66.68 USD | $246.85 269.84 USD | $248.1 271.21 USD | $133.4B 145.83B USD | 25.65 | $9.67 10.57 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$138.54B — | $0 — | $95.78 — | $95.78 — | $138.54B — | 20.12 | $4.76 — | |
| Bristol-Myers Squibb Company BMY.BA | $19,000 22.46 USD |
+3.54
|
$114.46T 135.3B USD | $476 0.56 USD | $18,700 22.1 USD | $19,050 22.52 USD | $114.46T 135.3B USD | 6.13 | $3.1K 3.66 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GILD.VI | $97.07 106.11 USD |
+1.18
|
$120.75B 131.99B USD | $288 314.82 USD | $95.71 104.62 USD | $97.07 106.11 USD | $120.75B 131.99B USD | 23.22 | $4.18 4.57 USD | |
| Gilead Sciences, Inc. GIS.DE | $97.06 106.1 USD |
+1.09
|
$120.74B 131.98B USD | $302 330.13 USD | $95.32 104.2 USD | $97.32 106.38 USD | $120.74B 131.98B USD | 23.10 | $4.2 4.59 USD | |
| Gilead Sciences, Inc. GIS.F | $97 106.03 USD |
+1.08
|
$120.66B 131.9B USD | $48 52.47 USD | $97 106.03 USD | $97.34 106.41 USD | $120.66B 131.9B USD | 23.09 | $4.2 4.59 USD | |
| Pfizer Inc. PFE.VI | $20.58 22.5 USD |
-0.6
|
$117B 127.9B USD | $3.37K 3.68K USD | $20.11 21.98 USD | $20.7 22.63 USD | $117B 127.9B USD | 17.00 | $1.21 1.32 USD | |
| Pfizer Inc. PFE.SN | $22.18 — |
-14.89
|
$126.1B — | $0 — | $22.18 — | $22.18 — | $126.1B — | 16.07 | $1.38 — | |
| Pfizer Inc. PFEB.F | $6.5 7.11 USD |
-2.26
|
$114.88B 125.58B USD | $5 5.47 USD | $6.5 7.11 USD | $6.5 7.11 USD | $114.88B 125.58B USD | 15.85 | $0.41 0.45 USD | |
| Sanofi SNW2.F | $45.6 49.85 USD |
-0.44
|
$112.43B 122.9B USD | $120 131.18 USD | $45.6 49.85 USD | $46.2 50.5 USD | $112.43B 122.9B USD | 18.23 | $2.5 2.73 USD | |
| Sanofi SANO.VI | $91.88 100.44 USD |
-0.55
|
$112.3B 122.76B USD | $0 0 USD | $91.88 100.44 USD | $92.58 101.2 USD | $112.3B 122.76B USD | 18.41 | $4.99 5.45 USD | |
| Sanofi SNW.F | $91.66 100.2 USD |
-0.93
|
$111.87B 122.29B USD | $1.01K 1.1K USD | $91.66 100.2 USD | $92.7 101.33 USD | $111.87B 122.29B USD | 18.36 | $4.99 5.45 USD | |
| GSK plc GSK.BA | $11,900 14.07 USD |
+3.48
|
$96.54T 114.11B USD | $72 0.09 USD | $11,725 13.86 USD | $11,900 14.07 USD | $96.54T 114.11B USD | 20.01 | $594.55 0.7 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $267.68 54.25 USD |
+1.23
|
$545.76B 110.62B USD | $0 0 USD | $0 0 USD | $0 0 USD | $545.76B 110.62B USD | 17.69 | $15.13 3.07 USD | |
| Bristol-Myers Squibb Company BMY.MX | $875 51.81 USD |
0
|
$1.84T 109.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.84T 109.14B USD | 16.92 | $51.71 3.06 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BRM.F | $42.06 45.98 USD |
+2.59
|
$86.5B 94.56B USD | $180 196.76 USD | $42.06 45.98 USD | $42.09 46 USD | $86.5B 94.56B USD | 17.74 | $2.37 2.59 USD | |
| GSK plc GSKN.MX | $711 42.1 USD |
+3.18
|
$1.58T 93.39B USD | $0 0 USD | $711 42.1 USD | $711 42.1 USD | $1.58T 93.39B USD | 17.94 | $39.62 2.35 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $41.73 45.62 USD |
+0.85
|
$85.04B 92.96B USD | $0 0 USD | $41.41 45.26 USD | $41.92 45.82 USD | $85.04B 92.96B USD | 17.75 | $2.35 2.57 USD | |
| Bristol-Myers Squibb Company BRM.DE | $41.68 45.56 USD |
+0.71
|
$84.92B 92.83B USD | $406 443.81 USD | $41.41 45.26 USD | $41.82 45.71 USD | $84.92B 92.83B USD | 17.66 | $2.36 2.58 USD | |
| GSK plc G1SK34.SA | $44.54 9.03 USD |
-0.85
|
$451.65B 91.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $451.65B 91.54B USD | 19.19 | $2.32 0.47 USD | |
| Chugai Pharmaceutical CHGCF | $54.41 — |
-2
|
$89.54B — | $2.2K — | $52.05 — | $54.41 — | $89.54B — | 31.45 | $1.73 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $45.67 49.92 USD |
+0.53
|
$75.85B 82.91B USD | $22 24.05 USD | $45.67 49.92 USD | $46 50.28 USD | $75.85B 82.91B USD | 29.84 | $1.53 1.67 USD | |
| GSK GLAXF | $18.71 — |
-3.85
|
$79.67B — | $1.19K — | $18.71 — | $19.96 — | $79.67B — | 18.89 | $0.99 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $23.8 26.02 USD |
-0.46
|
$44.52B 48.66B USD | $165 180.37 USD | $23.75 25.96 USD | $23.9 26.13 USD | $44.52B 48.66B USD | 25.05 | $0.95 1.04 USD | |
| Bayer Aktiengesellschaft BAYZF | $28.19 — |
+0.39
|
$27.89B — | $480 — | $28.11 — | $28.22 — | $27.89B — | 0 | -$3.76 — | |
| Bayer Aktiengesellschaft BAYER.BD | $10,034 27.75 USD |
-0.04
|
$9.86T 27.26B USD | $60 0.17 USD | $10,034 27.75 USD | $10,150 28.07 USD | $9.86T 27.26B USD | 0 | -$1,341 -3.7 USD | |
| Biogen Inc. BIIB.BA | $12,225 14.45 USD |
+6.3
|
$22.97T 27.16B USD | $19.34K 22.86 USD | $11,900 14.07 USD | $12,250 14.48 USD | $22.97T 27.16B USD | 1.04 | $11.7K 13.83 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $24.73 27.03 USD |
+0.08
|
$24.3B 26.56B USD | $26 28.42 USD | $24.72 27.02 USD | $24.97 27.29 USD | $24.3B 26.56B USD | 0 | -$3.32 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6 6.56 USD |
0
|
$24.24B 26.49B USD | $585 639.48 USD | $6 6.56 USD | $6 6.56 USD | $24.24B 26.49B USD | 0 | -$0.83 -0.9 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $41.2 45.04 USD |
0
|
$21.93B 23.97B USD | $25 27.33 USD | $41.2 45.04 USD | $41.8 45.69 USD | $21.93B 23.97B USD | 10.35 | $3.98 4.35 USD | |
| Biogen Inc. BIIB34.SA | $121.44 24.61 USD |
0
|
$107.19B 21.73B USD | $0 0 USD | $0 0 USD | $0 0 USD | $107.19B 21.73B USD | 12.82 | $9.47 1.92 USD | |
| Biogen Inc. BIIB.MX | $2,445 144.77 USD |
0
|
$360.33B 21.34B USD | $0 0 USD | $0 0 USD | $0 0 USD | $360.33B 21.34B USD | 12.53 | $195.11 11.55 USD | |
| Biogen Inc. BIIB.VI | $115.3 126.04 USD |
+0.96
|
$16.89B 18.47B USD | $0 0 USD | $112.6 123.09 USD | $115.3 126.04 USD | $16.89B 18.47B USD | 12.98 | $8.88 9.71 USD | |
| Biogen Inc. IDP.DE | $115.25 125.98 USD |
+0.52
|
$16.89B 18.46B USD | $133 145.39 USD | $113 123.52 USD | $115.25 125.98 USD | $16.89B 18.46B USD | 12.90 | $8.93 9.76 USD | |
| Biogen Inc. IDP.F | $113.6 124.18 USD |
+0.53
|
$16.65B 18.2B USD | $7 7.65 USD | $113.6 124.18 USD | $114.05 124.67 USD | $16.65B 18.2B USD | 12.72 | $8.93 9.76 USD | |
| Astellas Pharma ALPMF | $9.36 — |
-2.66
|
$17.39B — | $100 — | $9.36 — | $9.36 — | $17.39B — | 46.79 | $0.2 — | |
| Astellas Pharma Inc. YPHA.F | $8.2 8.96 USD |
-1.2
|
$15.29B 16.71B USD | $680 743.33 USD | $8.2 8.96 USD | $8.2 8.96 USD | $15.29B 16.71B USD | 48.23 | $0.17 0.19 USD | |
| Astellas Pharma Inc. YPH.F | $8.22 8.98 USD |
-0.92
|
$15.2B 16.61B USD | $10 10.93 USD | $8.22 8.98 USD | $8.45 9.24 USD | $15.2B 16.61B USD | 48.32 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,478 17.88 USD |
+0.1
|
$1.19T 14.44B USD | $5.54K 67.04 USD | $1,474.7 17.84 USD | $1,488.9 18.01 USD | $1.19T 14.44B USD | 22.64 | $65.26 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $51.65 56.46 USD |
-0.58
|
$10.63B 11.62B USD | $0 0 USD | $51.65 56.46 USD | $52.15 57.01 USD | $10.63B 11.62B USD | 25.82 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $51.45 56.24 USD |
-0.58
|
$10.6B 11.59B USD | $9 9.84 USD | $51.45 56.24 USD | $51.95 56.79 USD | $10.6B 11.59B USD | 25.72 | $2 2.19 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.8399 0.92 USD |
+10.59
|
$9.69B 10.59B USD | $1K 1.09K USD | $0.8399 0.92 USD | $0.8399 0.92 USD | $9.69B 10.59B USD | 16.75 | $0.05 0.05 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.16 3.45 USD |
+8.22
|
$9.55B 10.44B USD | $500 546.57 USD | $3.16 3.45 USD | $3.16 3.45 USD | $9.55B 10.44B USD | 17.55 | $0.18 0.2 USD | |
| CSPC Pharmaceutical CHJTF | $0.81 — |
+26.56
|
$9.93B — | $36K — | $0.81 — | $0.81 — | $9.93B — | 16.19 | $0.05 — | |
| Orion Oyj ORINY | $33.52 — |
+1.54
|
$9.23B — | $294 — | $33.52 — | $33.52 — | $9.23B — | 23.44 | $1.43 — | |
| Orion Oyj OFK0.F | $29.2 31.92 USD |
0
|
$8.21B 8.98B USD | $0 0 USD | $29.2 31.92 USD | $29.2 31.92 USD | $8.21B 8.98B USD | 23.54 | $1.24 1.36 USD | |
| Orion Oyj OFK.F | $57.6 62.96 USD |
-0.43
|
$8.11B 8.87B USD | $4 4.37 USD | $57.6 62.96 USD | $57.85 63.24 USD | $8.11B 8.87B USD | 23.22 | $2.48 2.71 USD | |
| Kyowa Kirin KYKOF | $15.8 — |
+3.74
|
$8.27B — | $100 — | $15.8 — | $15.8 — | $8.27B — | 23.23 | $0.68 — | |
| Grifols GIFLF | $10.45 — |
+9.69
|
$8.19B — | $676 — | $10.45 — | $10.45 — | $8.19B — | 40.20 | $0.26 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $13.6 14.87 USD |
0
|
$7.22B 7.89B USD | $50 54.66 USD | $13.6 14.87 USD | $13.7 14.98 USD | $7.22B 7.89B USD | 22.66 | $0.6 0.66 USD | |
| Abbott India Limited ABBOTINDIA.NS | $30,290 366.46 USD |
-0.2
|
$643.64B 7.79B USD | $792 9.58 USD | $30,130 364.52 USD | $30,455 368.45 USD | $643.64B 7.79B USD | 45.57 | $664.67 8.04 USD | |
| Abbott India Limited ABBOTINDIA.BO | $30,200 365.37 USD |
-0.45
|
$641.73B 7.76B USD | $33 0.4 USD | $30,160.55 364.89 USD | $30,350 367.18 USD | $641.73B 7.76B USD | 45.45 | $664.39 8.04 USD | |
| Orion Oyj ORINF | $48.65 — |
+3.16
|
$7.63B — | $4.53K — | $48.65 — | $48.65 — | $7.63B — | 19.69 | $2.47 — | |
|
لا توجد أسهم مفضَّلة
لا توجد لديك أسهم مفضَّلة حتى الآن؛ لذا يُرجى إضافتها إلى المفضَّلة لرؤيتها هنا |
||||||||||
- {{ link.label }} {{link}}